Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 8,345 | 11,691 | 4,152 | 18,152 | 3,927 |
| Gross Profit | 8,345 | 11,691 | 4,152 | 18,152 | 3,927 |
| Operating Expenses | 16,149 | 13,934 | 12,288 | 11,665 | 9,111 |
| Operating Income | -7,804 | -2,243 | -8,136 | 6,487 | -5,184 |
| Interest Expense | 0 | 0 | -325 | 0 | 0 |
| Other Income | 1,651 | 1,892 | -903 | 1,147 | -1,729 |
| Pre-tax Income | -6,153 | -351 | -8,714 | 7,634 | -6,913 |
| Income Tax | N/A | -148 | N/A | 143 | 146 |
| Net Income Continuous | -6,153 | -203 | -8,714 | 7,491 | -7,059 |
| Net Income | $-6,153 | $-203 | $-8,714 | $7,491 | $-7,059 |
| EPS Basic Total Ops | -8.80 | -0.30 | -13.60 | 14.40 | -12.80 |
| EPS Basic Continuous Ops | -9.10 | -0.30 | -13.93 | 14.02 | -12.72 |
| EPS Diluted Total Ops | -8.80 | -0.30 | -13.60 | 14.40 | -12.80 |
| EPS Diluted Continuous Ops | -9.10 | -0.30 | -13.93 | 14.02 | -12.72 |
| EBITDA(a) | $-7,674 | $-2,102 | $-8,002 | $6,588 | $-5,129 |